Fundz

Pulse Biosciences Appoints Burke T. Barrett as President and CEO, and Kevin Danahy as Chief Commercial Officer

PUBLIC · PLSEMay 14, 2024

Position

Chief Commercial Officer

Company

Pulse Biosciences, Inc.

Kevin Danahy
kevin.danahy@pulsebiosciences.com
HaywardBiotechnologyHealth CareMedicalTherapeutics

Description

Pulse Biosciences announced the appointment of Burke T. Barrett as President and Chief Executive Officer, while Kevin Danahy, former President and Chief Executive Officer, has been appointed as the Chief Commercial Officer to lead the pilot launch of the recently FDA cleared CellFX nsPFA Percutaneous Electrode System.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Pulse Biosciences, Inc., and when

A new leader at Pulse Biosciences, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Pulse Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pulse Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pulse Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pulse Biosciences, Inc.

Location

3957 POINT EDEN WAY

Hayward, California, United States

About

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation™ (nsPFA™) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pulse Biosciences, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kevin
Likely contact at this company
••••••••@••••••••

See Kevin's verified email →

John
Senior decision-maker at this company
••••••••@••••••••

See John's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Pulse Biosciences, Inc.'s next move

Learn about Strategic plan

Pulse Biosciences, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.